HOME >> BIOLOGY >> NEWS
Elderly patients denied best treatment for fear of side effects

This release is also available in French, Italian, and German.

Most elderly women with advanced ovarian cancer are not given optimal treatment for fear of an adverse reaction, although there is little evidence to show that they are at greater risk than younger patients, say oncologists in France. The results of an investigation involving 83 women over the age of 70 were announced today (20 October 2002) and will help oncologists identify which patients are most like to benefit from standard chemotherapy.

Speaking at the European Society for Medical Oncology Congress in Nice, France, Dr Gilles Freyer from Centre Hospitalier Lyon Sud, France, said, "We simply do not know if elderly patients can tolerate these powerful drugs, because clinical trials often exclude patients over the age of 70 years, so the results that emerge are not fully representative of the age range of patients we have to treat."

There are a number of factors that have to be taken into account when planning a treatment strategy for older people. They may be more vulnerable to the toxic side effects of the therapy. They experience more psychological problems, such as depression, and it can be difficult for an oncologist to communicate effectively with an elderly person if their cognition is impaired. Transport to and from hospital is one of the practical difficulties for older people.

Patients who are depressed before treatment begins, patients who lack autonomy and those living in institution are at risk of toxicity and the treatment may be less effective. "Perhaps this is because they are more fragile and need more care than elderly women who lead independent lives," Dr Freyer suggested. Medication being taken at the same time for other
'"/>

Contact: Gracemarie Bricalli
gracemarie@esmo.org
0041-91-973-1911
European Society for Medical Oncology
20-Oct-2002


Page: 1 2

Related biology news :

1. Striking A Healthy Balance For The Elderly
2. Dietary Determinants Of Iron Stores In A Free-Living Elderly Population: The Framingham Heart Study
3. Study Reviews Medication Use In Elderly Cardiac Patients After Discharge
4. Trial shows which brain cancer patients benefit from temozolomide
5. Study of flu patients reveals virus outsmarting key drug
6. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
7. Activated signaling pathway may predict lung cancer patients response to gefitinib
8. Targeted therapy for lung cancer patients shows promise in extending lives
9. Breast cancer patients failed by treatment with taxol and taxotere respond to abraxane
10. Study finds that only half of a commonly used cancer drug is activated in cancer patients
11. APP reports Abraxane(TM) is active in breast cancer patients who failed taxol or taxotere

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... Texas (PRWEB) , ... December 04, 2018 , ... ... supplier, has announced the much-anticipated launch of their 100-liter (26 gallon) SAFEthread Drum. ... SAFEthread Drum in 2017, which brought a much-needed modern redesign to the ...
(Date:11/29/2018)... Calif. (PRWEB) , ... November 29, 2018 , ... ... Technologies, is excited to collaborate with the new NSF Engineering Research Center for ... and clinical collaborators brought together to develop transformative tools and technologies for the ...
(Date:11/27/2018)... (PRWEB) , ... November 26, 2018 , ... ... Dr. Brandon Wuerth, MD, Founder of the website IBDwatch and Gastroenterology Fellow at ... leading scientists and doctors from around the world, Dr. Wuerth will bring to ...
Breaking Biology News(10 mins):
(Date:11/13/2018)... ... November 12, 2018 , ... Dr. Dan ... and Sandy Springs, now welcomes new patients for MTM® Clear Aligners. Offering a ... to traditional braces in the Sandy Springs and Alpharetta areas. Constantly on the ...
(Date:11/9/2018)... ... 2018 , ... uBiome, the leader in microbial genomics, announces ... of Andes Biotechnologies, to its Scientific Advisory Board. Joining the board of leading ... on the genetic studies of hepatitis viruses. The appointment will help uBiome continue ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial ... trial data collection and management. TrialKit ™, an eClinical platform, has incorporated ... can quickly and easily sign in to the app via facial recognition or ...
(Date:11/3/2018)... Va. (PRWEB) , ... November 01, 2018 , ... ... first-ever Metrics Champion Consortium Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical ... manage risk, monitor safety and ensure data reliability. , What should clinical research ...
Breaking Biology Technology:
Cached News: